Association of the P-glycoprotein transporter MDR1C3435T polymorphism with the susceptibility to renal epithelial tumors

Journal of the American Society of Nephrology

Volumn 13, Issue 7, 2002, Pages 1847-1854

  Siegsmund, Michael ^a   Brinkmann, Ulrich ^a   Schäffeler, Elke ^a   Weirich, Gregor ^a   Schwab, Matthias ^a   Eichelbaum, Michel ^a   Fritz, Peter ^a   Burk, Oliver ^a   Decker, Jochen ^a   Alken, Peter ^a   Rothenpieler, Uwe ^a   Kerb, Reinhold ^a   Hoffmeyer, Sven ^a   Brauch, Hiltrud ^a  

^a DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN 1; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; CANCER CELL; CANCER RISK; CELL MEMBRANE; CHROMOPHOBE ADENOMA; CLEAR CELL CARCINOMA; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY ADENOMA; KIDNEY CARCINOMA; KIDNEY PARENCHYMA; KIDNEY TUMOR; MAJOR CLINICAL STUDY; MALE; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; RISK FACTOR;

EID: 18444404305     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000019412.87412.BC     Document Type: Article

References (39)

1. Classification of renal cell carcinoma
2. Somatic mutations of the von Hippel-Lindau disease tumour suppressor gene in non-familial clear cell renal carcinoma
3. Mutations of the VHL tumour suppressor gene in renal carcinoma
4. VHL alterations in human clear cell renal cell carcinoma: Association with advanced tumor stage and a novel hot spot mutation
5. The candidate tumor suppressor gene, RASSF 1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis
6. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas
7. Novel mutations of the MET proto-oncogene in papillary renal carcinomas
8. Birt-Hogg-Dube syndrome, a genodermatosis associated with spontaneous pneumothorax and kidney neoplasia, maps to chromosome 17p11.2
9. Rising incidence of renal cell cancer in the United States
10. Trichloroethylene exposure and specific somatic mutations in patients with renal cell carcinoma
11. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: A study of polymorphic human xenobiotic-metabolizing enzymes
12. Association of GSTT1 non-null and NAT1 slow/rapid genotypes with von Hippel-Lindau tumour suppressor gene transversions in sporadic renal cell carcinoma
13. Biochemical, cellular, and pharmacological aspects of the multidrug transporter
14. The barrier function of CYP3A4 and P-glycoprotein in the small bowel
15. P-glycoprotein and multidrug resistance
16. The physiological function of drug-transporting P-glycoproteins
17. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues
18. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues
19. The multidrug-resistance P-glycoprotein (Pgp, MDR1) is an early marker of blood-brain barrier development in the microvessels of the developing human brain
20. P-Glycoprotein, a gatekeeper in the blood-brain barrier
21. Functional polymorphisms of the human multidrug-resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo
22. Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects
23. Frequency of C3435T polymorphism of MDR1 gene in African people
24. Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines
25. P-glycoproteins and multidrug resistance
26. Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: A pharmacogenetics study
27. The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells
28. Differential expression of drug metabolizing enzymes in primary and secondary liver neoplasm: Immunohistochemical characterization of cytochrome P4503A and glutathione-S-transferase
29. Immunohistochemical quantification of steroid receptors and other prognosis factors in human breast cancer patients
30. The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin
31. The von Hippel-Lindau tumour suppressor protein: New perspectives
32. Pavletich NP: Structure of the VHL-ElonginC-ElonginB complex: Implications for VHL tumor suppressor function
33. Pharmacological insights from P-glycoprotein knockout mice
34. The biochemistry of P-glycoprotein-mediated multidrug resistance
35. Physical-chemical properties shared by compounds that modulate multidrug resistance in human leukemic cells
36. Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics
37. Kidney tumors in Africa. Incidence and anatomo-clinical aspects. Apropos of 123 observed cases at the Central Hospital and at the University Hospital Center in Cameroon
38. MDR1 pharmacogenetics: Frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity
39. Effect of ABC transporters on HIV-1 infection: Inhibition of virus production by the MDR1 transporter